Altria
MO
$74.92
+0.13%
Altria Group, Inc. is a leading tobacco company in the United States, primarily engaged in the manufacture and sale of cigarettes, smokeless tobacco, and machine-made cigars through its subsidiaries Philip Morris USA, U.S. Smokeless Tobacco, and John Middleton. As the dominant player in the U.S. tobacco market, Altria's Marlboro brand commands a 40% market share, and the company also holds strategic stakes in Anheuser-Busch InBev and cannabis producer Cronos. The current investor narrative centers on Altria's transition toward reduced-risk products, including its acquisition of Njoy Holdings and its heated tobacco joint venture, while the stock's high dividend yield and recent revenue growth from smokeable products have attracted income-focused investors amid debates about the sustainability of its core cigarette business.…
MO
Altria
$74.92
Related headlines
MO 12-Month Price Forecast
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Altria's 12-month outlook, with a consensus price target around $70.64 and implied upside of -5.7% versus the current price.
Average Target
$70.64
0 analysts
Implied Upside
-5.7%
vs. current price
Analyst Count
—
covering this stock
Price Range
$59 - $82
Analyst target range
Altria is covered by 11 analysts, with a consensus recommendation of 'hold' and an average target price of $70.64. The current price of $72.99 implies a 3.2% downside to the average target, indicating a neutral to slightly bearish near-term outlook. The recommendation breakdown includes 4 buys, 5 holds, and 2 sells (based on the mean recommendation of 2.64 on a 1-5 scale). The target price range spans from a low of $59.00 to a high of $82.00, representing a 39% spread, which reflects significant uncertainty about the company's future. The high target of $82.00 assumes successful execution in reduced-risk products and continued dividend growth, while the low target of $59.00 prices in regulatory headwinds and declining cigarette volumes. Recent ratings from UBS (Buy), Barclays (Underweight), and Citigroup (Neutral) show a mixed but stable sentiment, with no recent upgrades or downgrades in the past three months.
Bulls vs Bears: MO Investment Factors
Altria presents a classic yield vs. risk trade-off. The bull case rests on its 7.2% dividend yield, accelerating revenue growth, and defensive low-beta profile, which have driven a 22.4% one-year return. The bear case centers on secular decline in cigarette volumes, a stretched payout ratio, and a leveraged balance sheet. Currently, the bull case has stronger evidence given the recent revenue acceleration and strong free cash flow, but the key tension is whether Altria can transition to reduced-risk products fast enough to offset core volume declines. If Njoy and heated tobacco gain traction, the stock could re-rate higher; if not, the dividend may become unsustainable.
Bullish
- High Dividend Yield of 7.2%: Altria offers a dividend yield of 7.2%, supported by a payout ratio of 100.2% and TTM free cash flow of $8.6 billion. This makes it one of the highest-yielding stocks in the S&P 500, attracting income-focused investors.
- Strong Revenue Growth Acceleration: Q1 2026 revenue grew 20.1% year-over-year to $5.43 billion, driven by smokeable products. This marks a significant acceleration from prior quarters, indicating robust pricing power and volume resilience.
- Dominant Market Position with 40% Share: Marlboro holds a 40% market share in U.S. cigarettes, providing pricing power and brand loyalty. This allows Altria to pass on excise tax increases to consumers, supporting margins.
- Low Beta of 0.49 Provides Defensive Stability: With a beta of 0.49, Altria is significantly less volatile than the market. This makes it a defensive holding during economic uncertainty, as evidenced by its 22.4% one-year return versus the S&P 500's 16.5%.
Bearish
- Declining Cigarette Volumes Long-Term: U.S. cigarette consumption has been declining at 3-5% annually due to health awareness and regulation. Altria's core business faces secular headwinds, and reduced-risk products have not yet offset volume declines.
- High Payout Ratio Limits Dividend Growth: The payout ratio of 100.2% leaves little room for dividend increases unless earnings grow. While free cash flow covers the dividend, any earnings pressure could force a cut, which would be a major negative catalyst.
- Negative Debt-to-Equity of -7.34: Liabilities exceed shareholders' equity, indicating a leveraged balance sheet. Although operating cash flow is strong, the negative equity raises financial risk, especially if interest rates remain elevated.
- Analyst Consensus Hold with Downside to Target: The average analyst target of $70.64 implies a 3.2% downside from the current price of $72.99. With 5 holds and 2 sells among 11 analysts, near-term sentiment is cautious.
MO Technical Analysis
Altria is in a sustained uptrend, with the stock price up 22.4% over the past year, significantly outperforming the S&P 500's 16.5% gain. The current price of $72.99 sits at 96.9% of its 52-week range (low $54.70, high $75.28), indicating strong momentum and positioning near the upper end of its yearly range, which suggests bullish sentiment but also potential overextension. Short-term momentum is mixed: the 1-month price change is +1.3%, while the 3-month change is +9.1%, showing deceleration from the longer-term trend. The 1-month relative strength versus the S&P 500 is 0.50, indicating neutral short-term performance, but the 1-year relative strength of 5.98 highlights consistent outperformance. The stock's beta of 0.49 implies it is significantly less volatile than the market, making it a defensive holding. Key support lies at the 52-week low of $54.70, while resistance is at the 52-week high of $75.28. A breakout above $75.28 would signal a continuation of the uptrend, while a breakdown below $54.70 could indicate a trend reversal. The low beta suggests limited downside risk relative to the broader market.
Beta
0.49
0.49x market volatility
Max Drawdown
-19.1%
Largest decline past year
52-Week Range
$55-$77
Price range past year
Annual Return
+26.2%
Cumulative gain past year
| Period | MO Return | S&P 500 |
|---|---|---|
| 1m | +1.2% | -1.6% |
| 3m | +3.1% | +1.5% |
| 6m | +20.9% | +5.4% |
| 1y | +26.2% | +14.8% |
| ytd | +30.7% | +7.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MO Fundamental Analysis
Altria's revenue trajectory is accelerating, with Q1 2026 revenue of $5.428 billion, up 20.1% year-over-year, driven primarily by smokeable products ($4.758 billion) and smokeless products ($669 million). This marks a significant improvement from the prior year's Q1 revenue of $4.519 billion, and the multi-quarter trend shows consistent growth from $5.106 billion in Q4 2024 to $5.848 billion in Q4 2025. The company is highly profitable, with Q1 2026 net income of $2.183 billion and a gross margin of 64.6%, though this is down from 72.6% in Q3 2025. Operating margin of 54.5% remains robust, reflecting strong pricing power and cost control. Altria generates substantial free cash flow, with TTM free cash flow of $8.623 billion and Q1 2026 free cash flow of $2.231 billion. However, the balance sheet shows a negative debt-to-equity ratio of -7.34, indicating that liabilities exceed shareholders' equity, which is typical for companies with large share buybacks and dividends. The current ratio of 0.61 suggests limited short-term liquidity, but strong operating cash flow ($2.324 billion in Q1 2026) provides ample coverage for debt service and dividends.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+20.1%
YoY Comparison
Gross Margin
64.6%
Latest Quarter
Free Cash Flow
$8.6B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MO Overvalued?
Given Altria's positive net income, the primary valuation metric is the P/E ratio. The trailing P/E is 14.0x, while the forward P/E is 12.4x, implying that earnings are expected to grow, which is consistent with the company's recent revenue acceleration. Compared to the industry average (not provided, but typically for tobacco, P/E ratios range 10-15x), Altria's forward P/E of 12.4x appears reasonable. Historically, Altria's trailing P/E has ranged from 5.2x (Q2 2024) to 23.8x (Q1 2025), and the current 14.0x is near the middle of this range, suggesting fair valuation. The P/S ratio of 4.8x is below the historical average of around 15x, indicating potential undervaluation on a sales basis. The dividend yield of 7.2% is attractive and supported by a payout ratio of 100.2%, which is high but sustainable given strong free cash flow.
PE
14.0x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 5x~13x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
10.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Altria's balance sheet shows a negative debt-to-equity ratio of -7.34, indicating that liabilities exceed shareholders' equity, a common result of massive share buybacks and dividends. The current ratio of 0.61 suggests limited short-term liquidity, though operating cash flow of $2.32 billion in Q1 2026 provides ample coverage. The payout ratio of 100.2% means all earnings are paid as dividends, leaving no buffer for earnings declines. If revenue growth decelerates or margins compress, the dividend could be at risk. Additionally, gross margin fell from 72.6% in Q3 2025 to 64.6% in Q1 2026, signaling potential cost pressures or product mix shifts.
Market & Competitive Risks: Altria faces secular decline in cigarette volumes (3-5% annually) and regulatory threats such as FDA flavor bans or nicotine caps. The stock's forward P/E of 12.4x is reasonable but not cheap relative to historical lows of 5.2x. With a beta of 0.49, it is less sensitive to macro swings, but rising interest rates could make its 7.2% yield less attractive relative to risk-free rates. Competition from Philip Morris International's IQOS and other vaping products could erode market share. Recent news highlights that smoke-free struggles remain a key risk for long-term investors.
Worst-Case Scenario: A severe regulatory crackdown (e.g., menthol ban) combined with accelerated volume declines could slash earnings. If the dividend is cut, the stock could fall to the 52-week low of $54.70, a 25% downside from $72.99. In a prolonged downturn, the stock could test the analyst low target of $59.00, representing a 19% loss. Historical max drawdown of -19.15% provides a reference, but a dividend cut could exceed that.